Summary
4D Molecular Therapeutics Inc
Founded in 2014
Description
4DMT is a biotechnology company that designs, develops, and commercializes transformative gene therapeutic products for serious unmet medical conditions. They are focused on unlocking the full potential of genetic medicines for large market diseases. T...
Strengths
- 4D Molecular Therapeutics Inc has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since 4D Molecular Therapeutics Inc was founded, the company has grown faster than the industry average
- Web traffic rankings are better than the industry average
Weaknesses
- Variance of revenue growth is more than the industry average
Annual Revenue
4D Molecular Therapeutics Inc's annual revenue
$17257000
Based on Kona Equity data
-
Revenue per employee
$125964
-
Variance of revenue growth
0.36
-
Annual revenue growth since founding
$1725700
-
Revenue growth rate from first known quarter to current
-18.8%
Employee Count
137 employees
-
Employee growth rate from first known quarter to current
81.4%
Executives
Gabriel Brooks
Vice President 4D Molecular Therapeutics
g**@4dmoleculartherapeutics.comAn Song
Chief Development Officer (Cdo)
a**@4dmoleculartherapeutics.comDavid Kirn
CEO
d**@4dmoleculartherapeutics.comHai Le
Director, Information Technology Operations & Security
h**@4dmoleculartherapeutics.comJoseph Leonetti
Associate Director, CMC Project Management
j**@4dmoleculartherapeutics.comRaphael Schiffmann
Senior VP& Therapeutic Area Head, Cardiology
r**@4dmoleculartherapeutics.comThomas Mason
Scientist
t**@4dmoleculartherapeutics.comFred Kamal
President & Chief Operating & Technical Officer
f**@4dmoleculartherapeutics.comScott Bizily
Chief Legal Officer
s**@4dmoleculartherapeutics.comAugust Moretti
Chief Financial Officer
a**@4dmoleculartherapeutics.comTheresa Janke
Chief Strategy Officer
t**@4dmoleculartherapeutics.comCasey Case
Senior VP, Research & Development
c**@4dmoleculartherapeutics.comBrian Fritts
Senior Network Engineer
b**@4dmoleculartherapeutics.comAnthony Baldor
Business Development
a**@4dmoleculartherapeutics.comAnthony Davies
Chief Operating Officer
a**@4dmoleculartherapeutics.comKatie Hoover
Director, Trial Master File Operations
k**@4dmoleculartherapeutics.comCarolyne Zimmermann
Chief Business Officer
c**@4dmoleculartherapeutics.comAngelique Mittan
Senior Director, Clinical Operations
a**@4dmoleculartherapeutics.comDenise Brisco
Manager, Accounts Payable
d**@4dmoleculartherapeutics.comDavid Asarnow
Director, Quality & Compliance
d**@4dmoleculartherapeutics.comKim Maplestone
Vice President, Clinical Operations
k**@4dmoleculartherapeutics.comKevin Whittlesey
Vice President, Translational Medicine
k**@4dmoleculartherapeutics.comJinsong Shen
Associate Director
j**@4dmoleculartherapeutics.comSteve Herrick
Senior Director, Pharmacovigilance
s**@4dmoleculartherapeutics.comTimothy Chen
Vice President, Research & Development, Biologics
t**@4dmoleculartherapeutics.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
- G7 Website traffic rankings are better than the industry average
Web Analysis
-
Rank
2.08 M
-
Page views per visitor
2.0
-
Daily time
-
Location
Unlock unlimited leads
Similar Companies
Asklepios BioPharmaceutical , Inc.
askbio.com- Founded in 2001
- Location: Durham, NC
- Annual Revenue: $19.4M
- Employees: 859
- AskBio is a leading clinical stage gene therapy company dedicated to developing AAV gene therapies for genetic and complex disorders. AskBio is a fully integrated molecular medicine and technology company with operations around the globe. Its robust pi...
Adverum Biotechnologies
adverum.com- Founded in 2006
- Location: Redwood City, CA
- Annual Revenue: $7.5M
- Employees: 188
- Adverum Biotechnologies is a clinical stage company that aims to establish gene therapy as a new standard of care for highly prevalent ocular diseases. Their mission is to develop functional cures through gene therapy to restore vision and prevent blin...
MeiraGTx
meiragtx.com- Founded in 2015
- Location: New York City, NY
- Annual Revenue: $38.7M
- Employees: 315
- MeiraGTx is a gene therapy company committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. They are pioneering the use of gene therapy to treat devastating neurodegenerati...
Voyager Therapeutics, Inc.
voyagertherapeutics.com- Founded in 2013
- Location: Cambridge, MA
- Annual Revenue: $194.9M
- Employees: 125
- Unlocking breakthroughs in AAV gene therapy and developing best-in-class treatments for CNS and other diseases.
REGENXBIO
regenxbio.com- Founded in 2009
- Location: Rockville, MD
- Annual Revenue: $480.0M
- Employees: 372
- REGENXBIO is a leading biotechnology company focused on the development, commercialization, and licensing of recombinant adeno-associated virus (AAV) gene therapy. Their proprietary AAV gene delivery platform consists of exclusive rights to over 100 no...
Applied Genetic Technologies Corp.
agtc.com- Founded in 1999
- Location: Alachua, Florida
- Annual Revenue: $325.0K
- Employees: 102
- Applied Genetic Technologies Corp (AGTC) is a biotechnology company that develops cures for rare lung and eye diseases using gene therapy. AGTC uses the non-toxic adeno-associated virus (AAV) to deliver healthy copies of genes to replace defective ones...
Key Information
- Name: 4D Molecular Therapeutics Inc
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 87; 873
- NAICS: 5417; 541
See similar companies
-
By City Emeryville Small Biotechnology Company in Emeryville Mid-size Biotechnology Company in Emeryville Pharmaceuticals in Emeryville Small Pharmaceuticals in Emeryville Mid-size Pharmaceuticals in Emeryville
-
By State CA Small companies in CA Pharmaceuticals in CA Small Pharmaceuticals in CA Mid-size Pharmaceuticals in CA Small Biotechnology Company in CA Mid-size Biotechnology Company in CA
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 6 Founded in 2014 SIC: 87 SIC: 873 NAICS: 5417 NAICS: 541 #Education General #Organizations General #Education #Organizations
Frequently Asked Questions
4D Molecular Therapeutics Inc's headquarters are located at 5858 Horton St. Ste. 455 460 Emeryville, CA 94608.
4D Molecular Therapeutics Inc's official website is 4dmoleculartherapeutics.com
4D Molecular Therapeutics Inc's annual revenue is $17.3 M.
4D Molecular Therapeutics Inc's SIC: 87; 873
4D Molecular Therapeutics Inc's NAICS: 5417; 541.
4D Molecular Therapeutics Inc has 137 employees
4D Molecular Therapeutics Inc is in the industry of Pharmaceuticals.
